Here is evidence that metformin, especially at high doses and for long periods, is associated with increased risk for neurodegenerative diseases and dementia.
Understanding the Clinical Utility of Low-Contrast Letter Acuity and RAN Tasks in Alzheimer Disease
Episode 113: Lessons Learned in Alzheimer Drug Development
This Week on NeurologyLive® — April 22, 2024
Paradigm Shift in Parkinson’s Disease Diagnosis
NeurologyLive® Brain Games: April 21, 2024
Cerevel’s Tavapadon Meets Primary End Point in Phase 3 TEMPO-3 Study of Parkinson Disease